Image pharmaphorum Editor Market Access Reuters Pharma USA 2023 - Day 1 Thanks for joining us here in the City of Brotherly Love for the start of this year's Reuters Pharma USA conference. Market Access Reuters Pharma USA 2023 On March 28th and 29th, industry leaders from across the pharmaceutical ecosystem will descend on Philadelphia for Reuters Pharma USA 2023. Oncology 12 Questions with David Long David Long leads the Oncology Business Unit at MSD in the UK and brings a wealth of experience from his 20 years within the organisation, having held a variety of local, regional and global R&D Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023 Americas FT US Pharma & Biotech Summit 16-17-May New York, US Load more results
Market Access Reuters Pharma USA 2023 - Day 1 Thanks for joining us here in the City of Brotherly Love for the start of this year's Reuters Pharma USA conference.
Market Access Reuters Pharma USA 2023 On March 28th and 29th, industry leaders from across the pharmaceutical ecosystem will descend on Philadelphia for Reuters Pharma USA 2023.
Oncology 12 Questions with David Long David Long leads the Oncology Business Unit at MSD in the UK and brings a wealth of experience from his 20 years within the organisation, having held a variety of local, regional and global
R&D Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023 Americas FT US Pharma & Biotech Summit 16-17-May New York, US
News Agios mulls early FDA filing for sickle cell therapy Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
